USCOM LIMITED — Regulatory Filings 2014

Mar 2, 2014

Uscom Limited ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au

==> picture [57 x 49] intentionally omitted <==

M A R K E T A N N O U N C E M E N T

Uscom appoints new German distributor

Monday 3rd of March 2014: Uscom (ASX code: UCM)

Uscom Limited is pleased to announce the appointment of SMT Medical as an USCOM 1A distributor for the German market.

SMT Medical was established 10 years ago and functions as a master distributor into the German market. The Company specialises in innovative cardiovascular products for clinical and research applications and public health programs. The Company has several product specialists with 20 or more years experience in cardiovascular applications and sales of Doppler ultrasound devices. The 3 year contract represents a best endeavours commitment to generate 2.7m AUD revenue over the term of the agreement.

The German medical device market is the third biggest in the world consisting of approximately 500,000 beds and 2,000 Hospitals serving a population of 82m people. The market is also one of the most sophisticated and wealthy supported by a total Healthcare spend of 12% of GDP.

Executive Chairman of Uscom, Rob Phillips said, “We are delighted to appoint SMT to sell USCOM into the wealthy and sophisticated German medical device market. SMT have strong sales channels and an experienced team who understand Doppler ultrasound and recognize the value of the advanced USCOM technology. The appointment of SMT is further evidence of our growing distribution and sales reach, a reach directly connected to revenue.”

Uscom manufactures and markets the USCOM 1A and the Uscom BP+, both premium cardiovascular devices changing the way we diagnose and treat circulatory disease, including hypertension and heart failure. The two products are also integral for optimising management of sepsis and guidance of fluid, inotropes and vasoactive therapies.

Uscom Limited ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au

==> picture [57 x 49] intentionally omitted <==

M A R K E T A N N O U N C E M E N T

About Uscom

Uscom Limited is an ASX listed cardiovascular medical device company (UCM). Uscom is an innovative developer and manufacturer of premium cardiovascular devices and has two practice leading technologies in the field of cardiovascular monitoring, the USCOM 1A and the BP+. The devices are both clinically validated with FDA, CE and TGA regulatory approval, and are currently being marketed into global distribution networks.

The USCOM 1A is a simple, cost-effective and non-invasive device that measures heart function, detects irregularities and guides treatment. The USCOM device has major applications in Paediatrics, Emergency, Intensive Care Medicine and Anesthesia, and is the device of choice for management of adult and paediatric sepsis, and for the guidance of fluid therapy.

The Uscom BP+ is a supra systolic Central Blood Pressure monitor and replaces older and more widespread BP sub systolic Blood Pressure monitoring technology. Central Blood Pressure is becoming the new standard of care measurement in hypertension and heart failure. The Uscom BP+ provides highly accurate and repeatable measurements of central and brachial blood pressure and pulse pressure waveforms using a familiar upper arm cuff. The BP+ is simple to use and requires no complex training with applications in cardiology, intensive care, general practice and home care.

For more information, please visit: http://www.uscom.com.au

Uscom Contacts Rob Phillips Executive Chairman rob@uscom.com.au

Catherine Officer Company Secretary secretary@uscom.com.au